Log In
Print
BCIQ
Print
Print this Print this
 

RG2833

  Manage Alerts
Collapse Summary General Information
Company Repligen Corp.
DescriptionSelective histone deacetylase 3 (HDAC3) inhibitor
Molecular Target Histone deacetylase 3 (HDAC3)
Mechanism of ActionHistone deacetylase (HDAC) inhibitor
Latest Stage of DevelopmentPhase I
IndicationAtaxia
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today